An observational study in Mets, sponsored by Far Eastern Memorial Hospital. Completed at 1 site in Taiwan. Per ClinicalTrials.gov, last updated 2022-03-22.
Sponsored by Far Eastern Memorial Hospital · Observational
Application of Decision Analysis Techniques' in Huge Health-checkup Database to Explore the High-risk Group With Metabolic Syndrome (MetS)
According to the American Heart Association（AHA）modified Adult Treatment Panel III（ATP-III） and the criteria of Health Promotion Administration, Taiwan. Five indices are used to define metabolic syndrome（MetS): including waist circumference （WC), high blood pressure（H/P）, fasting plasma glucose（FPG）, triglyceride（TG）, and high-density lipoprotein-cholesterol（HDL-C）. The recent researches showed us, there was no research applying the five criteria into their decision model. This study proposal will be the first study which evaluated the importance of the criteria related to apply these indices and decision model into the clinic for risk factors assessment.
This study was divided into 2 stages: (1) to analyze the big database of health examination to find out the major decision-making analysis module of MetS, including the level of importance and decision-making weight of 5 indicators, which can be provided as reference for suggestions on clinical medical treatments or health education focuses of health management of sub-health population; (2) to analyze other demographic variables of the database (educational background, residence, occupation, etc.) and the variables affecting health patterns (including smoking, drinking, long-term sitting work pattern) to find out the important variables affecting high risk group for MetS among populations of all ages, in order to investigate the improvement strategies for early prevention or intervention of important variables. As aging society is coming, it is estimated that the elderly people over the age of 65 in Taiwan will reach 20% by 2025. According to the estimation of Executive Yuan, the growth rate of healthcare service industry will reach at least 17%, and the annual output value will reach USD 18 billion. Therefore, this study intends to develop strategies for preventing chronic illness in the middle-aged and elderly people and find out the characteristic variables of high risk group according to different age groups to further reduce the incidence of MetS or CVD.
1,964 studies on the registry are indexed under Metabolic Syndrome; 330 are open to participants now.
This study's enrollment of 100,000 is above the median of 200 across 458 observational studies indexed under Metabolic Syndrome.
Browse Metabolic Syndrome studies →Far Eastern Memorial Hospital is the lead sponsor of 253 studies on the registry; 38 are open to participants now.
Counted across the registry records on this site, refreshed daily.
As aging society is coming, it is estimated that the elderly people over the age of 65 in Taiwan will reach 20% by 2025. According to the estimation of Executive Yuan, the growth rate of healthcare service industry will reach at least 17%, and the annual output value will reach USD 18 billion. Therefore, this study intends to develop strategies for preventing chronic illness in the middle-aged and elderly people and find out the characteristic variables of high risk group according to different age groups to further reduce the incidence of MetS or CVD.
Exclusion Criteria:
analyze the big database of health examination to find out the major decision-making analysis module of MetS
This study plans to use decision analysis and new statistical techniques, including decision tree algorithms; random forest algorithms; multivariate linear regression combinations and hierarchical linear models, and with a large number of health databases. Analysis, through the comprehensive health check report and physiological indicator data accumulated over many years, find more key variables or physiological indicators that can be used to evaluate MetS or CVD, in order to provide government departments, medical institutions or nationals early Detect or prevent, and further reduce the overall rate of MetS in Taiwan at this stage.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Far Eastern Memorial Hospital